Activity content starts in:
Industry Webcast
Exploring Use of Antiarrhythmic Drugs in the Era of Atrial Fibrillation AblationIndustry Webcast Sponsored by Sanofi; Not for CME/CE Credit
This virtual meeting will examine the role of anti-arrhythmic drugs (AADs) in the treatment of atrial fibrillation (AF), with an emphasis on how to optimize safety and effectiveness. Attendees will explore overall treatment strategies to decrease the burden of AF, the use of AADs for maintenance of rhythm control, and treatment strategies post catheter ablation. The session will closely reference the 2023 ACC/AHA/ACCP/HRS AF Guideline, with key considerations highlighted through use of a case study and interactive polling questions.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 7/8/2026
Expiration Date: 7/8/2027
Topics
Faculty
Faculty
Janet K. Han, MD, FHRS
Learn MoreSupporters and Partners
Industry Sponsor
Sanofi
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.